This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Takeda Pharmaceutical Company Limited. Active years: 2017.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2017
Title: Vladimir Stepanov: Innovator in Radiolabeled Compounds
Introduction
Vladimir Stepanov is a notable inventor based in Stockholm, Sweden. He has made significant contributions to the field of radiolabeled compounds, particularly in their application as radiotracers for imaging purposes. His work is essential for advancing medical imaging techniques.
Latest Patents
Vladimir Stepanov holds a patent for "Radiolabeled compounds and their use as radiotracers for quantitative imaging of phosphodiesterase (PDE10A) in mammals." This invention provides radiolabeled compounds that are useful as radiotracers for quantitative imaging of PDE10A in mammals. The compound is represented by a specific formula, with each symbol defined in the patent specification. He has 1 patent to his name.
Career Highlights
Vladimir Stepanov is currently employed at Takeda Pharmaceutical Company Limited, where he continues to innovate in the field of pharmaceuticals and medical imaging. His work at Takeda has allowed him to collaborate with other talented professionals in the industry.
Collaborations
He has worked alongside notable colleagues such as Takahiko Taniguchi and Shotaro Miura, contributing to various projects that enhance the understanding and application of radiolabeled compounds.
Conclusion
Vladimir Stepanov's contributions to the field of radiolabeled compounds are invaluable. His innovative work in medical imaging continues to pave the way for advancements in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile